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Epithelial sodium channel regulatory proteins identified by func-
tional expression cloning. We describe here our current strategy
for identifying and cloning proteins involved in the regulation of
the epithelial sodium channel (ENaC). We have set up a comple-
mentation functional assay in the Xenopus laevis oocyte expression
system. Using this assay, we have been able to identify a channel-
activating protease (CAP-1) that can increase ENaC activity
threefold. We propose a novel extracellular signal transduction
pathway controlling ionic channels of the ENaC gene family that
include genes involved in mechanotransduction (degenerins), in
peptide-gated channels involved in neurotransmission (FaNaCh),
in proton-gated channels involved in pH sensing (ASIC) or pain
sensation (DRASIC).
The highly selective, amiloride-sensitive, epithelial Na
channel (ENaC) is the rate-limiting step for Na reabsorp-
tion in the distal renal tubule, the distal colon, the distal
ducts of several exocrine glands, and the airways. The
activity of ENaC in kidney and colon is tightly controlled by
aldosterone and is thus involved in the maintenance of Na
balance and blood pressure [1, 2]. Aldosterone is a potent
regulator of transepithelial Na transport in all vertebrates
from amphibia to mammals. Aldosterone binds to an
intracellular receptor, and the active hormone-receptor
complex interacts with hormone-responsive elements in
promoters of specific genes, hence modulating their tran-
scription and leading to the expression and/or repression of
specific proteins (AIP or ARP) [3, 4]. Candidate targets for
the action of these proteins are the apical Na channel, the
apical K channel, the Na,K pump, the basolateral K
channel, and the tight junction proteins. As a general
working hypothesis, we postulate that the gene network,
which is under the specific control of aldosterone in renal
epithelia, represents a set of candidate genes involved in
the control of Na homeostasis and blood pressure through
the aldosterone-dependent electrogenic Na transport pro-
cess. Candidate genes belong to two categories: proteins
that transport Na, that is, the Na pump and the Na channel,
and regulatory proteins controlling the activity of these
proteins. Over the past 15 years, our laboratory has been
involved in identifying and characterizing the Na channel
and the Na pump. Major efforts were directed first to the
molecular characterization of Na,K-adenosine triphos-
phatase from tight epithelia and its control by aldosterone
[3]. More recently, we became interested in identifying the
apical Na channel, technically a more difficult endeavor.
Using functional expression cloning in Xenopus oocytes, we
first identified tissues expressing the highest Na channel
density (kidney and colon) using either a 22Na-uptake assay
[5] or a measurement of an amiloride-inhibitable Na cur-
rent by a two-electrode voltage-clamp method [6]. With the
latter method, we isolated from rat distal colon epithelial
cells a cDNA identified by functional expression of an
amiloride-sensitive Na current in Xenopus oocytes [7]. The
Na current observed after a rENaC cRNA injection into
the oocytes was smaller than that observed after injection
of size-fractionated poly A1 RNA isolated from the tissue
of origin, suggesting the existence of other subunits mod-
ulating the expression of the channel in the plasma mem-
brane. At the same time, a rENaC had been characterized
by Lingueglia et al [8]. Second, we designed a novel
complementation functional assay to clone silent compo-
nents of the channel that alone may have little Na channel
activity but are of critical importance for the reconstitution
of a fully active channel. Using our functional complemen-
tation assay, we were able to identify two other subunits (b
and g) [9]. The ion-selective permeability, the gating prop-
erties, and the pharmacological profile of the channel
formed by coexpressing the three subunits in the oocyte
were similar to those of the native channel. The a, b, and
g subunits from different species and from different organs
have now also been reported by different groups, as
reviewed in [10].
Recently, we have cloned the channel protein from A6
kidney cell [11], a cell line that expresses both the highly
Na-selective channel (type 1) and the moderately selective
channel (type 2). The biophysical characteristics are well
conserved between rat and frog, suggesting molecular
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conservation as well. Three homologous subunits have
been identified and coexpressed in the Xenopus oocyte
system [11]. The reconstituted channel showed all the
characteristics of the native type 1 ENaC described in A6
cells: high Na selectivity (Li . Na .. K), low single-
channel conductance (4 to 6 pS in presence of Na), slow
gating kinetics (seconds), and high affinity for amiloride
(submicromolar range). Transcript a, b, and g subunits of
Xenopus ENaC have been detected in A6 kidney cells and
in Xenopus kidney, lung, and, to a lesser extent, stomach
and skin. Each Xenopus ENaC subunit shares about 60%
overall identity with the corresponding rat homologue (a,
b, and g rENaC), whereas subunits share only 35% iden-
tity. Our data suggest that the triplication of the ENaC
subunits occurred before the divergence between mamma-
lian and amphibian lineages.
We have examined the effect of aldosterone on ENaC
mRNA abundance and the rate of protein synthesis for
each of the three ENaC subunits in the A6 Xenopus kidney
cell line [12]. In cells grown on a porous substrate, amilo-
ride-sensitive electrogenic Na transport is expressed and is
up-regulated by aldosterone (300 nM) after one hour. a, b,
and g-mRNA abundance is not changed by aldosterone
during the first three hours stimulation but increases four-
fold over control after 24 hours. The rate of a-subunit
protein synthesis is significantly increased above control
after 60 minutes. b-Subunit synthesis increases only after
six hours, and there is no significant change for the g
subunit. The half-lives of each subunit were short (40 to 50
min), as assessed by 35S methionine pulse-chase experi-
ments, and were not modified by aldosterone [12]. Taking
into account the short half-life of ENaC protein and
assuming that the synthesis of the a subunit is a limiting
factor in the assembly and expression of new channels at
the cell surface, we have proposed that the aldosterone
regulation of Na transport might be, in part, mediated by de
novo synthesis and assembly of the channel protein [12].
One of our current aims is to define regulatory proteins
that could control Na channel activity. We would like to
identify proteins that interact either directly or indirectly
with the channel protein to control its activity. To address
this question, three different strategies are currently avail-
able.
The first strategy is to identify the proteins interacting
directly with the Na channel. Because the cytoplasmic
domains of the protein (the N terminus and C terminus)
are short (about 9 kDa), the number of interactions may be
rather limited. Affinity columns can be designed, using
either the N terminus or the C terminus of each subunit, to
isolate cytoplasmic components that can bind selectively to
these two domains. This approach has been used success-
fully to identify a spectrin as interacting directly with the C
terminus of a rENaC [13] and, more recently, Nedd-4 [14]
that interacts with the C termini of the a, b, and g subunits.
In this study, the double-hybrid cloning technique in yeast
was used to identify interacting proteins. This is a powerful
method for identifying any protein(s) that interacts directly
with each other.
The second strategy for identifying regulatory proteins
under the control of aldosterone is to use either a cDNA
differential subtractive approach, as used by Attali et al
[15], or the now popular technique of differential display
reverse transcription-polymerase chain reaction. The latter
may be difficult due to large numbers of false positive and
negative clones but nevertheless has been used successfully
by Franc¸ois Verrey in Zurich [16]. For both approaches,
the demonstration of the physiological relevance of the
identified genes remains difficult.
The third strategy designed in our laboratory is the use of
a complementation functional assay that allows selection of
gene products that can regulate the activity of the Na
channel expressed in the oocyte. This approach has allowed
us to clone two silent subunits (b and g) of the Na channel
[9]. The same technique may also be used to identify
regulatory proteins induced by aldosterone. Both activators
and repressors of channel activity may be cloned by expres-
sion in the oocyte. In this report, we discuss briefly the
results we have obtained recently using this approach.
CONSTRUCTION OF THE A6 CDNA LIBRARY AND
CLONING STRATEGY
The A6 cell line is a Xenopus kidney cell line that
expresses a high degree of epithelial differentiation and
regulation [17]. A6 cells grown on filters exhibit transepi-
thelial Na transport that can be stimulated by aldosterone.
The time course of aldosterone action on Na transport and
ENaC expression can be divided into three steps: a latent
period (30 to 45 minutes), an early phase (45 minutes to
hours) in which Na transport increases and transepithelial
electrical resistance falls, but without significant changes in
ENaC mRNA abundance, and a late phase (3 to 24 hours)
in which Na transport increases further without change in
transepithelial electrical resistance but with a significant
increase in ENaC mRNA abundance [12]. Assuming that a
regulatory protein(s) should be induced by aldosterone
during the latent period, A6 cells were grown on filters and
stimulated with aldosterone for 45 minutes before recovery
of mRNA. After 45 minutes, the transepithelial Na current
just began to increase (by about 1.4-fold: 5.9 6 0.09
mA/cm22 with aldosterone vs. 4.2 6 0.02 mA/cm22 in
control). Total RNA was then extracted and polyA1
mRNA purified by oligo(dT) column affinity. To obtain a
restricted cDNA library, we size fractionated the mRNA by
sucrose gradient centrifugation, and six mRNA fractions
(0.5 and 5 kb) were tested for their ability to increase ENaC
activity. Each fraction (50 ng mRNA per oocyte) was
injected into oocytes together with a near saturating
amount (0.3 ng of each subunit per oocyte) of abg-ENaC
cRNA. ENaC activity was then measured as an amiloride-
sensitive Na current. A current of 224.2 6 45.8 nA (N 5 6)
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was observed in oocytes injected with ENaC cRNA alone.
This activity was roughly doubled in oocytes coinjected with
the mRNA from fraction seven (466.6 6 109.9 nA; N 5 6;
P , 0.07). The other fractions had no significant potential
effect on channel activity or, in some fractions, even
decreased ENaC activity (Fig. 1). The fraction seven
(mRNA size 1 to 2 kb) was used to construct a cDNA
oligo(dT)-primed directional library by cloning into the
pSPORT1 expression vector. To minimize species differ-
ences, all probes were prepared from Xenopus laevis: the
cDNA library was constructed from the A6 Xenopus kidney
cell line and screened by coinjection of the Xenopus ENaC
subunits into Xenopus oocytes.
Our cloning assay consisted of coexpression into oocytes
of the cRNA encoding the three ENaC subunits together
with cRNA transcribed from a library, followed by mea-
surements of ENaC activity as an amiloride-sensitive Na
current by the two-electrode voltage-clamp method [6]
(Fig. 2). The total library was divided into 10 different
cDNA pools. Each pool was transcribed in vitro and
coinjected into oocytes together with the three (a, b, and g)
ENaC subunits, and ENaC activity was measured. The pool
associated with the highest amiloride-sensitive Na current
was then subdivided for further screening.
SCREENING THE LIBRARY
The whole cDNA library (named A8) contained approx-
imately 30,000 independent cDNA clones. For screening,
plasmids were extracted, linearized using the NotI enzyme,
and in vitro transcribed to synthesized cRNA. When the
cRNA from the unfractionated cDNA library was coin-
jected together with ENaC subunits in the oocytes, there
was no increase in ENaC activity (Fig. 3). In the first round
of screening, the library was subdivided into 10 pools, each
containing about 2,500 clones (A8.1–A8.10). The func-
tional assays showed that the A8.1 pool increased ENaC
activity by 187%. This pool was subdivided into a further 10
pools (A8.1.1–A8.1.10) that were screened in the second
round. The A8.1.8 pool, containing about 200 clones,
increased ENaC activity by 300%. This pool was then
subdivided into seven pools (A8.1.8.1–A8.1.8.7), each of 30
clones. The A8.1.8.1 pool increased ENaC activity by
378%. To overcome the problem of day-to-day variability
of the expression system, the functional assay was per-
formed three times in three different batches of oocytes for
each of the three rounds of screening. Additionally, at least
two different cRNA preparations were injected, and at
least 10 oocytes were measured in each experiment. In the
Fig. 1. Screening of the mRNA sucrose
gradient. (A) A6 mRNA was size fractionated
by sucrose gradient centrifugation, and the
amount contained in each fraction was
quantified by measuring the absorbance at 260
nm (OD260; F). The fractions containing the
18S and 28S rRNA in the corresponding
polyA2 gradient were indicated. Fractions 5 to
10 were injected in oocytes to test their ability
to increase epithelial Na channel (ENaC)
activity (measured as amiloride-sensitive Na
current, INa; u). Each bar represents the mean
of six oocytes. Errors bars represent SEM. (B)
original current recordings obtained in oocytes
expressing ENaC alone (right panel) or ENaC
plus mRNA from the fraction seven (left
panel). The current sensitive to 5 mM amiloride
(am) was measured at 2100 mV. Oocytes
coinjected with fraction seven mRNA exhibit
larger current.
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fourth and final round, the 30 clones contained in the
A8.1.8.1 pool were isolated, and the plasmid of each clone
was digested by restriction enzymes to check the size of the
insert. Only 12 clones contained an insert allowing the
synthesis of a protein. The cRNA of these 12 clones was
then coinjected separately into oocytes. Only one of these
clones, the clone A8.1.8.1.3, was able to increase ENaC
activity by 330%. The overall screening procedure took 12
months.
The clone A8.1.8.1.3 was renamed CAP-1 for channel
activating protease. CAP-1 cDNA is 1340 bp long, and
sequence analysis revealed a 987-bp open reading frame
encoding a 329-amino acid protein. This protein shares
homologies with several members of the serine protease
family. The effect of CAP-1 on ENaC activity has been
characterized [18], and results indicate that CAP-1 specif-
ically increases ENaC activity about threefold. In many
respects, the activity of CAP-1 mimics that of extracellular
trypsin, as recently reported [19]. Experimental evidences
indicate that the action of CAP-1 occurs at the extracellular
surface of the cells, suggesting an effect on the large
extracellular loop of ENaC proteins, although proteolytic
cleavage of ENaC itself has not been demonstrated.
In summary, functional complementation cloning has
allowed us to identify a novel regulator of ENaC activity.
We have also identified a new pathway in which ENaC
activity can be modulated by an extracellular serine pro-
tease activity. This novel mechanism may be investigated in
the regulation of the activity of other members of ENaC
family, such as homologues expressed in neurons
(FaNaCh) [20], BNaC or ASIC/DRASIC [21–24], or mec-4
and mec-10, components of the mechanosensory complex
in Caenorhabditis elegans neurons [25]. We are currently
characterizing the biochemical and physiological properties
of CAP-1. Of interest, CAP-1 does not appear to be
regulated by aldosterone as we had anticipated from our
cloning strategy. Rather, CAP-1 seems to be constitutively
expressed in A6 cells and could be a limiting factor in
Fig. 2. Strategy of cloning by functional
complementation assay. mRNA extracted from
aldosterone stimulated A6 cells was size
fractionated by sucrose gradient centrifugation.
The fraction of interest was used to construct a
cDNA library in pSPORT1 expression vector.
The library was divided in 10 pools. The
plasmid DNA of each pool was isolated,
linearized, and in vitro transcribed to synthesize
cRNA. The cRNA was then injected in oocytes,
together with the three cRNA encoding a-, b-,
and g-epithelial Na channel (ENaC) subunits.
ENaC activity was measured as an amiloride-
sensitive Na current. The positive pool, leading
to an increase of ENaC activity, was then
subdivided and screened in a further round of
functional complementation assays.
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the physiological activation of ENaC. This idea is sup-
ported by the finding that aprotinin, a serine protease
inhibitor, fully inhibits amiloride-sensitive electrogenic Na
transport when present on the apical side of the monolayer
(Ki 0.6 mM) [19].
Our cloning strategy should allow us to isolate in the
future other regulatory proteins up- or down-regulating
ENaC activity. Loss or gain of functional mutations in the
genes responsible could lead to dysregulation of blood
volume or blood pressure as already shown for ENaC [2].
The approach has both pitfalls and advantages. On the
negative side, the method is time consuming and requires
high motivation. The well-known variability of the oocyte
expression system cannot be overcome without a statistical
approach that predicts the number of independent experi-
ments that have to be performed. The sensitivity of the
assay is not very high, but a 40% change in ENaC activity in
a defined mRNA fraction was enough to clone CAP-1,
providing that the cDNA library was restricted to a rather
small number of independent clones. In this study, 30,000
clones were counted, but probably only 50% contained an
insert capable of coding for a protein. On the positive side,
the technique allows the cloning of a fully functional (by
definition) cDNA so that the difficult problem of assigning
a function to a gene cloned by a classic method does not
arise. On the other hand, functional cloning does not give
access to the biochemistry of the identified molecule. This
step may be difficult, especially for a channel protein like
ENaC, but may possibly be less arduous for a serine
protease such as CAP-1.
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